Cargando…
Bromido[1-(η(6)-4-tert-butylbenzyl)-3-(2,4,6-trimethylbenzyl)benzimidazol-2-ylidene]chloridoruthenium(II)
A new ruthenium complex, [RuBrCl(C(28)H(32)N(2))], has been synthesized and characterized by elemental analysis, (1)H NMR, (13)C NMR, IR-spectroscopy and a single-crystal X-ray diffraction study. The Ru atom in this complex is best described as having a considerably distorted octahedral coordinatio...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967929/ https://www.ncbi.nlm.nih.gov/pubmed/21581560 http://dx.doi.org/10.1107/S1600536808042256 |
_version_ | 1782189728665174016 |
---|---|
author | Arslan, Hakan VanDerveer, Don Özdemir, İsmail Demir, Serpil Çetinkaya, Bekir |
author_facet | Arslan, Hakan VanDerveer, Don Özdemir, İsmail Demir, Serpil Çetinkaya, Bekir |
author_sort | Arslan, Hakan |
collection | PubMed |
description | A new ruthenium complex, [RuBrCl(C(28)H(32)N(2))], has been synthesized and characterized by elemental analysis, (1)H NMR, (13)C NMR, IR-spectroscopy and a single-crystal X-ray diffraction study. The Ru atom in this complex is best described as having a considerably distorted octahedral coordination environment with the arene occupying three coordination sites. Two further coordination sites are occupied by chloride and bromide ligands, while the sixth site is occupied by the carbene. The carbene portion of the ligand is a benzimidazole ring. This ring is connected to the C(6)H(4)C(CH(3))(3) arene by a CH(2) bridge. This leads to a system with very little apparent strain. The two halogen atoms are disordered between Br and Cl. Two partial Cl atoms share the same sites as two partial Br atoms so that the title compound effectively has one Cl and one Br atom. C—H⋯X (X = Cl, Br) hydrogen bonds help to stabilize the crystal structure. |
format | Text |
id | pubmed-2967929 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | International Union of Crystallography |
record_format | MEDLINE/PubMed |
spelling | pubmed-29679292010-12-30 Bromido[1-(η(6)-4-tert-butylbenzyl)-3-(2,4,6-trimethylbenzyl)benzimidazol-2-ylidene]chloridoruthenium(II) Arslan, Hakan VanDerveer, Don Özdemir, İsmail Demir, Serpil Çetinkaya, Bekir Acta Crystallogr Sect E Struct Rep Online Metal-Organic Papers A new ruthenium complex, [RuBrCl(C(28)H(32)N(2))], has been synthesized and characterized by elemental analysis, (1)H NMR, (13)C NMR, IR-spectroscopy and a single-crystal X-ray diffraction study. The Ru atom in this complex is best described as having a considerably distorted octahedral coordination environment with the arene occupying three coordination sites. Two further coordination sites are occupied by chloride and bromide ligands, while the sixth site is occupied by the carbene. The carbene portion of the ligand is a benzimidazole ring. This ring is connected to the C(6)H(4)C(CH(3))(3) arene by a CH(2) bridge. This leads to a system with very little apparent strain. The two halogen atoms are disordered between Br and Cl. Two partial Cl atoms share the same sites as two partial Br atoms so that the title compound effectively has one Cl and one Br atom. C—H⋯X (X = Cl, Br) hydrogen bonds help to stabilize the crystal structure. International Union of Crystallography 2008-12-20 /pmc/articles/PMC2967929/ /pubmed/21581560 http://dx.doi.org/10.1107/S1600536808042256 Text en © Arslan et al. 2009 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited. |
spellingShingle | Metal-Organic Papers Arslan, Hakan VanDerveer, Don Özdemir, İsmail Demir, Serpil Çetinkaya, Bekir Bromido[1-(η(6)-4-tert-butylbenzyl)-3-(2,4,6-trimethylbenzyl)benzimidazol-2-ylidene]chloridoruthenium(II) |
title | Bromido[1-(η(6)-4-tert-butylbenzyl)-3-(2,4,6-trimethylbenzyl)benzimidazol-2-ylidene]chloridoruthenium(II) |
title_full | Bromido[1-(η(6)-4-tert-butylbenzyl)-3-(2,4,6-trimethylbenzyl)benzimidazol-2-ylidene]chloridoruthenium(II) |
title_fullStr | Bromido[1-(η(6)-4-tert-butylbenzyl)-3-(2,4,6-trimethylbenzyl)benzimidazol-2-ylidene]chloridoruthenium(II) |
title_full_unstemmed | Bromido[1-(η(6)-4-tert-butylbenzyl)-3-(2,4,6-trimethylbenzyl)benzimidazol-2-ylidene]chloridoruthenium(II) |
title_short | Bromido[1-(η(6)-4-tert-butylbenzyl)-3-(2,4,6-trimethylbenzyl)benzimidazol-2-ylidene]chloridoruthenium(II) |
title_sort | bromido[1-(η(6)-4-tert-butylbenzyl)-3-(2,4,6-trimethylbenzyl)benzimidazol-2-ylidene]chloridoruthenium(ii) |
topic | Metal-Organic Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967929/ https://www.ncbi.nlm.nih.gov/pubmed/21581560 http://dx.doi.org/10.1107/S1600536808042256 |
work_keys_str_mv | AT arslanhakan bromido1ē64tertbutylbenzyl3246trimethylbenzylbenzimidazol2ylidenechloridorutheniumii AT vanderveerdon bromido1ē64tertbutylbenzyl3246trimethylbenzylbenzimidazol2ylidenechloridorutheniumii AT ozdemirismail bromido1ē64tertbutylbenzyl3246trimethylbenzylbenzimidazol2ylidenechloridorutheniumii AT demirserpil bromido1ē64tertbutylbenzyl3246trimethylbenzylbenzimidazol2ylidenechloridorutheniumii AT cetinkayabekir bromido1ē64tertbutylbenzyl3246trimethylbenzylbenzimidazol2ylidenechloridorutheniumii |